Camp4 Therapeutics (CAMP) Shares Issued (2023 - 2025)

Camp4 Therapeutics has disclosed Shares Issued across 3 years of filings, most recently posting $57.5 million for Q4 2025.

• Shares Issued for Q4 2025 came in at $57.5 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $57.5 million (changed N/A YoY), and the FY2025 annual result was $57.5 million, changed N/A from the prior year.
• Shares Issued came in at $57.5 million for Q4 2025 at Camp4 Therapeutics, up from $3000.0 in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $57.5 million in Q4 2025 to a low of -$2000.0 in Q3 2024.
• The 3-year median for Shares Issued is $3000.0 (2025), against an average of $11.5 million.
• Peak annual rise in Shares Issued reached 250.0% in 2025, while the deepest fall reached 250.0% in 2025.
• Camp4 Therapeutics' Shares Issued stood at $173000.0 in 2023, then tumbled by 101.16% to -$2000.0 in 2024, then surged by 2875750.0% to $57.5 million in 2025.
• The last three Shares Issued figures came in at $57.5 million (Q4 2025), $3000.0 (Q3 2025), and -$2000.0 (Q3 2024), per Business Quant data.